Induction Therapy With Chemoimmunotherapy Followed by Surgery for Unresectable Stage III Non-small Cell Lung Cancer: a Single-center, Single-arm, Prospective Clinical Study
Latest Information Update: 25 Sep 2021
At a glance
- Drugs Camrelizumab (Primary) ; Carboplatin (Primary) ; Paclitaxel (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms NEOSUN
- 27 Aug 2021 Status changed from not yet recruiting to recruiting.
- 17 Aug 2021 Planned initiation date changed from 18 Jul 2021 to 18 Aug 2021.
- 07 Jul 2021 New trial record